Papaldo P - Search Results

1

Single-agent vinorelbine in pretreated breast cancer patients: comparison of two different schedules.

Terzoli E, Nisticò C, Fabi A, Milella M, Bria E, D'Ottavio AM, Vaccaro A, Vanni B, Garufi C, Ferraresi V, Giannarelli D, Papaldo P, Carlini P, Izzo F, Cognetti F. Terzoli E, et al. Among authors: papaldo p. J Exp Clin Cancer Res. 2004 Jun;23(2):207-13. J Exp Clin Cancer Res. 2004. PMID: 15354404

2

Ifosfamide given by continuous-intravenous infusion in association with vinorelbine in patients with anthracycline-resistant metastatic breast cancer: a phase I-II clinical trial.

Campisi C, Fabi A, Papaldo P, Tomao S, Massidda B, Zappala A, Ionta MT, Cognetti F. Campisi C, et al. Among authors: papaldo p. Ann Oncol. 1998 May;9(5):565-7. doi: 10.1023/a:1008221109364. Ann Oncol. 1998. PMID: 9653499 Free article. Clinical Trial.

3

Breast cancer and timing of surgery during menstrual cycle: a 5-year analysis of 248 premenopausal women.

Milella M, Nisticò C, Ferraresi V, Vaccaro A, Fabi A, D'Ottavio AM, Botti C, Giannarelli D, Lopez M, Cortesi E, Foggi CM, Antimi M, Terzoli E, Cognetti F, Papaldo P. Milella M, et al. Among authors: papaldo p. Breast Cancer Res Treat. 1999 Jun;55(3):259-66. doi: 10.1023/a:1006276120841. Breast Cancer Res Treat. 1999. PMID: 10517170 Clinical Trial.

4

Toxicity and activity of docetaxel in anthracycline-pretreated breast cancer patients: a phase II study.

Ferraresi V, Milella M, Vaccaro A, D'Ottavio AM, Papaldo P, Nisticò C, Thorel MF, Marsella A, Carpino A, Giannarelli D, Terzoli E, Cognetti F. Ferraresi V, et al. Among authors: papaldo p. Am J Clin Oncol. 2000 Apr;23(2):132-9. doi: 10.1097/00000421-200004000-00006. Am J Clin Oncol. 2000. PMID: 10776972 Clinical Trial.

5

A phase II study on metastatic breast cancer patients treated with weekly vinorelbine with or without trastuzumab according to HER2 expression: changing the natural history of HER2-positive disease.

Papaldo P, Fabi A, Ferretti G, Mottolese M, Cianciulli AM, Di Cocco B, Pino MS, Carlini P, Di Cosimo S, Sacchi I, Sperduti I, Nardoni C, Cognetti F. Papaldo P, et al. Ann Oncol. 2006 Apr;17(4):630-6. doi: 10.1093/annonc/mdj110. Epub 2006 Jan 12. Ann Oncol. 2006. PMID: 16410363 Free article. Clinical Trial.

6

Second- and third-generation aromatase inhibitors as first-line endocrine therapy in postmenopausal metastatic breast cancer patients: a pooled analysis of the randomised trials.

Ferretti G, Bria E, Giannarelli D, Felici A, Papaldo P, Fabi A, Di Cosimo S, Ruggeri EM, Milella M, Ciccarese M, Cecere FL, Gelibter A, Nuzzo C, Cognetti F, Terzoli E, Carlini P. Ferretti G, et al. Among authors: papaldo p. Br J Cancer. 2006 Jun 19;94(12):1789-96. doi: 10.1038/sj.bjc.6603194. Epub 2006 May 30. Br J Cancer. 2006. PMID: 16736002 Free PMC article.

7

Ifosfamide given by continuous-intravenous infusion in association with vinorelbine in patients with anthracycline-resistant metastatic breast cancer: A phase I-II clinical trial.

Campisi C, Fabi A, Papaldo P, Tomao S, Massidda B, Zappala A, Ionta MT, Cognetti F. Campisi C, et al. Among authors: papaldo p. Cancer Chemother Pharmacol. 1999;44 Suppl:S1-4. doi: 10.1007/s002800051107. Cancer Chemother Pharmacol. 1999. PMID: 10602901 Clinical Trial.

8

Role of P53 and BCL-2 in high-risk breast cancer patients treated with adjuvant anthracycline-based chemotherapy.

Mottolese M, Benevolo M, Del Monte G, Buglioni S, Papaldo P, Nisticò C, Di Filippo F, Vasselli S, Vici P, Botti C. Mottolese M, et al. Among authors: papaldo p. J Cancer Res Clin Oncol. 2000 Dec;126(12):722-9. doi: 10.1007/pl00008478. J Cancer Res Clin Oncol. 2000. PMID: 11153146

9

Ifosfamide and epirubicin combination in untreated sarcomas: two treatment schedules.

Serrone L, Zeuli M, Papaldo P, Nardoni C, Pacetti U, Cognetti F. Serrone L, et al. Among authors: papaldo p. Onkologie. 2001 Oct;24(5):465-8. doi: 10.1159/000055127. Onkologie. 2001. PMID: 11694773 Clinical Trial.

10

Formestane, a steroidal aromatase inhibitor after failure of non-steroidal aromatase inhibitors (anastrozole and letrozole): is a clinical benefit still achievable?

Carlini P, Frassoldati A, De Marco S, Casali A, Ruggeri EM, Nardi M, Papaldo P, Fabi A, Paoloni F, Cognetti F. Carlini P, et al. Among authors: papaldo p. Ann Oncol. 2001 Nov;12(11):1539-43. doi: 10.1023/a:1013180214359. Ann Oncol. 2001. PMID: 11822752 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters